PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer
PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer have?
PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer has 80 citations in the OpenAlex counts ScholarIQ stores.
When was PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer published?
PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer has 2022 year in the ScholarIQ index.
What is the open-access status of PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer?
PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer has gold oa status in the ScholarIQ index.
What is the DOI of PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer?
The DOI for PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer is on the source record.
What is the PMID of PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer?
The PMID for PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer is on the source record.
What is the OpenAlex record for PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer?
The OpenAlex for PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer is on the source record.